JP2013542955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542955A5 JP2013542955A5 JP2013537733A JP2013537733A JP2013542955A5 JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5 JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- compound
- hcv
- compound according
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40898910P | 2010-11-01 | 2010-11-01 | |
| US61/408,989 | 2010-11-01 | ||
| PCT/US2011/058404 WO2012061248A2 (en) | 2010-11-01 | 2011-10-28 | Novel specific hcv ns3 protease inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542955A JP2013542955A (ja) | 2013-11-28 |
| JP2013542955A5 true JP2013542955A5 (https=) | 2015-02-12 |
| JP5828903B2 JP5828903B2 (ja) | 2015-12-09 |
Family
ID=46025037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537733A Expired - Fee Related JP5828903B2 (ja) | 2010-11-01 | 2011-10-28 | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8729014B2 (https=) |
| EP (1) | EP2635570B1 (https=) |
| JP (1) | JP5828903B2 (https=) |
| CN (1) | CN103328466B (https=) |
| AU (1) | AU2011323658A1 (https=) |
| BR (1) | BR112013010836A2 (https=) |
| CA (1) | CA2815855C (https=) |
| IL (1) | IL225908A0 (https=) |
| MX (1) | MX2013004906A (https=) |
| WO (1) | WO2012061248A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011268498A1 (en) | 2010-06-24 | 2013-01-31 | Genoscience Pharma Sas | Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent |
| WO2012061248A2 (en) | 2010-11-01 | 2012-05-10 | Rfs Pharma, Llc | Novel specific hcv ns3 protease inhibitors |
| US8912141B2 (en) | 2011-06-23 | 2014-12-16 | Panmed Ltd. | Treatment of hepatitis C virus |
| US9040479B2 (en) | 2012-01-12 | 2015-05-26 | Cocrystal Pharma, Inc. | HCV NS3 protease inhibitors |
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
| US9617310B2 (en) | 2013-03-15 | 2017-04-11 | Gilead Sciences, Inc. | Inhibitors of hepatitis C virus |
| JP2017513852A (ja) * | 2014-04-15 | 2017-06-01 | コクリスタル ファーマ，インコーポレイテッド | Ｃ型肝炎ウイルスの強力及び選択的な阻害剤 |
| CN105315261A (zh) * | 2014-08-04 | 2016-02-10 | 正大天晴药业集团股份有限公司 | Hcv ns3蛋白酶抑制剂的钠盐 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000536A1 (en) | 1993-06-22 | 1995-01-05 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds |
| AP1019A (en) | 1996-10-18 | 2001-10-16 | Vertex Pharma | Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease. |
| US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
| AU2001251165A1 (en) | 2000-04-03 | 2001-10-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| CA2462200A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| ES2361011T3 (es) | 2002-05-20 | 2011-06-13 | Bristol-Myers Squibb Company | Inhibidores del virus de la hepatitis c. |
| CA2531068A1 (en) | 2003-07-10 | 2005-01-27 | Achillion Pharmaceuticals, Inc. | Substituted arylthiourea derivatives useful as inhibitors of viral replication |
| PL1713822T3 (pl) | 2004-01-30 | 2010-08-31 | Medivir Ab | Inhibitory proteazy serynowej HCV NS-3 |
| DE602005015452D1 (de) | 2004-05-20 | 2009-08-27 | Schering Corp | Substituierte proline als hemmer der ns3-serinprotease des hepatits-c-virus |
| US7323447B2 (en) * | 2005-02-08 | 2008-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US20080191609A1 (en) | 2005-04-19 | 2008-08-14 | Koninklijke Philips Electronics N.V. | Illumination System Comprising a Red-Emitting Ceramic Luminescence Converter |
| AR057456A1 (es) | 2005-07-20 | 2007-12-05 | Merck & Co Inc | Inhibidores de la proteasa ns3 del vhc |
| NZ565269A (en) | 2005-08-01 | 2010-03-26 | Merck & Co Inc | Macrocyclic peptides as HCV NS3 protease inhibitors |
| US20090304631A1 (en) | 2006-01-27 | 2009-12-10 | David Alan Campbell | Hepatitis c serine protease inhibitors and uses therefor |
| CN101495457A (zh) * | 2006-07-05 | 2009-07-29 | 因特蒙公司 | C型肝炎病毒复制的新颖抑制剂 |
| RU2008152171A (ru) | 2006-07-05 | 2010-08-10 | Интермьюн, Инк. (Us) | Новые ингибиторы вирусной репликации гепатита с |
| US7635683B2 (en) | 2006-08-04 | 2009-12-22 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl tripeptide hepatitis C virus inhibitors |
| JP5035251B2 (ja) | 2006-11-24 | 2012-09-26 | 株式会社島津製作所 | Ｘ線透視撮影装置 |
| US20080287449A1 (en) | 2007-04-26 | 2008-11-20 | Deqiang Niu | Aza-tripeptide hepatitis c serine protease inhibitors |
| MX2010006210A (es) | 2007-12-05 | 2010-08-10 | Enanta Pharm Inc | Inhibidores de serina proteasa de hcv de tripeptido fluorado. |
| US8293705B2 (en) | 2007-12-21 | 2012-10-23 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
| TWI487522B (zh) * | 2007-12-21 | 2015-06-11 | 賽基艾維洛米斯研究股份有限公司 | Ｈｃｖ蛋白酶抑制劑及其用途（一） |
| WO2009142842A2 (en) | 2008-04-15 | 2009-11-26 | Intermune, Inc. | Novel macrocyclic inhibitors of hepatitis c virus replication |
| KR101781789B1 (ko) | 2010-01-27 | 2017-09-26 | 에이비 파르마 리미티드. | C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물 |
| WO2012061248A2 (en) | 2010-11-01 | 2012-05-10 | Rfs Pharma, Llc | Novel specific hcv ns3 protease inhibitors |
-
2011
- 2011-10-28 WO PCT/US2011/058404 patent/WO2012061248A2/en not_active Ceased
- 2011-10-28 CN CN201180063866.1A patent/CN103328466B/zh not_active Expired - Fee Related
- 2011-10-28 MX MX2013004906A patent/MX2013004906A/es active IP Right Grant
- 2011-10-28 CA CA2815855A patent/CA2815855C/en not_active Expired - Fee Related
- 2011-10-28 AU AU2011323658A patent/AU2011323658A1/en not_active Abandoned
- 2011-10-28 BR BR112013010836A patent/BR112013010836A2/pt not_active IP Right Cessation
- 2011-10-28 US US13/284,641 patent/US8729014B2/en not_active Expired - Fee Related
- 2011-10-28 JP JP2013537733A patent/JP5828903B2/ja not_active Expired - Fee Related
- 2011-10-28 EP EP11838590.5A patent/EP2635570B1/en not_active Not-in-force
-
2013
- 2013-04-23 IL IL225908A patent/IL225908A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542955A5 (https=) | ||
| JP2012528161A5 (https=) | ||
| JP2011528713A5 (https=) | ||
| JP2013510120A5 (https=) | ||
| JP2009504763A5 (https=) | ||
| JP2011079828A5 (https=) | ||
| JP2012504126A5 (https=) | ||
| JP2019526596A5 (https=) | ||
| JP2014504643A5 (https=) | ||
| JP2008530096A5 (https=) | ||
| JP2007535491A5 (https=) | ||
| EP2368900A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| JP2005524632A5 (https=) | ||
| RU2015114543A (ru) | Способы лечения гепатита с | |
| JP2011520906A5 (https=) | ||
| JP2010509359A5 (https=) | ||
| JP2012504132A5 (https=) | ||
| JP2010510233A5 (https=) | ||
| JP2012516871A5 (https=) | ||
| JP2012512169A5 (https=) | ||
| TN2012000009A1 (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
| JP2014508804A5 (https=) | ||
| JP2012504632A5 (https=) | ||
| JP2010510967A5 (https=) | ||
| JP2016040288A5 (https=) |